NYSE · CIK 0001047335
NHC NATIONAL HEALTHCARE CORP
Insider trading from SEC Form 4. Last filing 19 d ago. Close $227.11 on Oct 9, 2026, +96% from the 52-week low and -4% from the high.
Last 90 days
Net insider value
-$4.8M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
4
$4.8M by 4 insiders
Insiders on file
13
with a Form 4 at this company
Price and insider trades, last year
NHCOct 9, 2026 · close 227.11
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at NATIONAL HEALTHCARE CORP, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 65Notable | Vicki L Dodson Sr.VP Patient Srvcs sell | $1.1M 4,834 shares | -31% | - | |
| 67Notable | Brian F Kidd SVP, CFO sell | $1.5M 6,813 shares | -23% | - | |
| 55Moderate | Josh A McCreary Senior VP & General Counsel sell | $610k 2,719 shares | -21% | - | |
| 50Moderate | Ben Anderson Flatt Sr Senior VP & CIO sell | $1.6M 7,000 shares | -31% | - | |
| 33Weak | National Health Corp other sell | $3.2M 28,147 shares | -3% | - |
Transactions
The last 77 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | Vicki L Dodson Sr.VP Patient Srvcs | SOpen-market sale Shares of Common Stock held in my name | -4,834 | $225.00 | $1.1M | 10,726 | 19 d ago |
| Sep 11, 2026 | Brian F Kidd SVP, CFO | SOpen-market sale Common Stock | -6,813 | $225.70 | $1.5M | 23,183 | 28 d ago |
| Sep 10, 2026 | Josh A McCreary Senior VP & General Counsel | SOpen-market sale Common Stock | -571 | $222.73 | $127k | 12,127 | 28 d ago |
| Sep 10, 2026 | Josh A McCreary Senior VP & General Counsel | SOpen-market sale Common Stock | -789 | $223.78 | $177k | 11,338 | 28 d ago |
| Sep 10, 2026 | Josh A McCreary Senior VP & General Counsel | SOpen-market sale Common Stock | -1,291 | $225.09 | $291k | 10,047 | 28 d ago |
| Sep 10, 2026 | Josh A McCreary Senior VP & General Counsel | SOpen-market sale Common Stock | -68 | $225.59 | $15k | 9,979 | 28 d ago |
| Aug 12, 2026 | Ben Anderson Flatt Sr Senior VP & CIO | SOpen-market sale Common Stock | -1,000 | $221.21 | $221k | 21,636 | 40 d ago |
| Aug 14, 2026 | Ben Anderson Flatt Sr Senior VP & CIO | SOpen-market sale Common Stock | -1,000 | $222.11 | $222k | 20,636 | 40 d ago |
| Aug 17, 2026 | Ben Anderson Flatt Sr Senior VP & CIO | SOpen-market sale Common Stock | -1,000 | $226.00 | $226k | 19,636 | 40 d ago |
| Aug 19, 2026 | Ben Anderson Flatt Sr Senior VP & CIO | SOpen-market sale Common Stock | -1,000 | $237.18 | $237k | 18,636 | 40 d ago |
| Aug 20, 2026 | Ben Anderson Flatt Sr Senior VP & CIO | SOpen-market sale Common Stock | -1,000 | $237.00 | $237k | 17,636 | 40 d ago |
| Aug 25, 2026 | Ben Anderson Flatt Sr Senior VP & CIO | SOpen-market sale Common Stock | -1,000 | $227.00 | $227k | 16,636 | 40 d ago |
| Aug 28, 2026 | Ben Anderson Flatt Sr Senior VP & CIO | SOpen-market sale Common Stock | -1,000 | $222.50 | $223k | 15,636 | 40 d ago |
| Sep 19, 2025 | Robert G Adams director | MOption exercise Shares of Common Stock - Trust Iindirect: Trustee | +4,500 | $71.64 | $322k | 13,579 | Sep 23, 2025 |
| Sep 19, 2025 | Robert G Adams director | MOption exercise Option to Purchase Common Stock [2021 Grant]derivative | -4,500 | $0.00 | $0 | 0 | Sep 23, 2025 |
| Aug 22, 2025 | Stephen Fowler Flatt CEO | MOption exercise Common Stock | +2,000 | $53.94 | $108k | 60,756 | Aug 26, 2025 |
| Aug 22, 2025 | Stephen Fowler Flatt CEO | FTax withholding Common Stock | -1,363 | $114.82 | $156k | 59,393 | Aug 26, 2025 |
| Aug 22, 2025 | Stephen Fowler Flatt CEO | MOption exercise Common Stock | +2,000 | $94.10 | $188k | 61,393 | Aug 26, 2025 |
| Aug 22, 2025 | Stephen Fowler Flatt CEO | FTax withholding Common Stock | -1,783 | $114.82 | $205k | 59,610 | Aug 26, 2025 |
| Aug 22, 2025 | Stephen Fowler Flatt CEO | MOption exercise Option to Purchase Common Stockderivative | -2,000 | $0.00 | $0 | 8,000 | Aug 26, 2025 |
| Aug 22, 2025 | Stephen Fowler Flatt CEO | MOption exercise Option to Purchase Common Stockderivative | -2,000 | $0.00 | $0 | 13,000 | Aug 26, 2025 |
| Aug 13, 2025 | James Paul Abernathy director | MOption exercise Shares of Common Stock | +4,010 | $71.64 | $287k | 39,033 | Aug 15, 2025 |
| Aug 13, 2025 | James Paul Abernathy director | FTax withholding Shares of Common Stock | -2,639 | $108.82 | $287k | 36,394 | Aug 15, 2025 |
| Aug 13, 2025 | James Paul Abernathy director | MOption exercise Option to Purchase Common Stock [2021 Grant]derivative | -4,010 | $0.00 | $0 | 0 | Aug 15, 2025 |
| Jun 26, 2025 | Stephen Fowler Flatt CEO | MOption exercise Common Stock | +4,734 | $63.96 | $303k | 62,313 | Jun 30, 2025 |
| Jun 26, 2025 | Robert Michael Ussery President & COO | MOption exercise Common Stock | +4,234 | $63.96 | $271k | 159,955 | Jun 30, 2025 |
| Jun 26, 2025 | Stephen Fowler Flatt CEO | FTax withholding Common Stock | -3,557 | $109.05 | $388k | 58,756 | Jun 30, 2025 |
| Jun 26, 2025 | Robert Michael Ussery President & COO | FTax withholding Common Stock | -2,007 | $109.05 | $219k | 157,948 | Jun 30, 2025 |
| Jun 26, 2025 | Robert Michael Ussery President & COO | MOption exercise Option to Purchase Common Stockderivative | -4,234 | $0.00 | $0 | 0 | Jun 30, 2025 |
| Jun 26, 2025 | Stephen Fowler Flatt CEO | MOption exercise Option to Purchase Common Stockderivative | -4,734 | $0.00 | $0 | 0 | Jun 30, 2025 |
| Jun 26, 2025 | Vicki L Dodson Sr.VP Patient Srvcs | GGift Shares of Common Stock held in my name | -788 | $0.00 | $0 | 8,961 | Jun 26, 2025 |
| Jun 12, 2025 | Vicki L Dodson Sr.VP Patient Srvcs | MOption exercise Shares of Common Stock held in my name | +3,733 | $53.94 | $201k | 11,280 | Jun 16, 2025 |
| Jun 12, 2025 | Vicki L Dodson Sr.VP Patient Srvcs | FTax withholding Shares of Common Stock held in my name | -2,511 | $104.56 | $263k | 8,769 | Jun 16, 2025 |
| Jun 12, 2025 | Vicki L Dodson Sr.VP Patient Srvcs | MOption exercise Shares of Common Stock held in my name | +3,734 | $63.96 | $239k | 12,503 | Jun 16, 2025 |
| Jun 12, 2025 | Vicki L Dodson Sr.VP Patient Srvcs | FTax withholding Shares of Common Stock held in my name | -2,754 | $104.56 | $288k | 9,749 | Jun 16, 2025 |
| Jun 12, 2025 | Vicki L Dodson Sr.VP Patient Srvcs | MOption exercise Option to Purchase Common Stockderivative | -3,734 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 12, 2025 | Vicki L Dodson Sr.VP Patient Srvcs | MOption exercise Option to Purchase Common Stockderivative | -3,733 | $0.00 | $0 | 3,734 | Jun 16, 2025 |
| Jun 6, 2025 | Josh A McCreary Senior VP & General Counsel | MOption exercise Common Stock | +3,734 | $63.96 | $239k | 11,258 | Jun 10, 2025 |
| Jun 6, 2025 | Josh A McCreary Senior VP & General Counsel | FTax withholding Common Stock | -2,805 | $106.10 | $298k | 8,453 | Jun 10, 2025 |
| Jun 6, 2025 | Josh A McCreary Senior VP & General Counsel | MOption exercise Option to Purchase Common Stockderivative | -3,734 | $0.00 | $0 | 0 | Jun 10, 2025 |
| Jun 3, 2025 | Richard F Laroche Jr director | GGift Common Stock - Held in my name or my wife's name | -152 | $104.69 | $16k | 205,760 | Jun 5, 2025 |
| May 16, 2025 | Brian F Kidd SVP, CFO | MOption exercise Common Stock | +3,734 | $63.96 | $239k | 26,415 | May 20, 2025 |
| May 16, 2025 | Brian F Kidd SVP, CFO | FTax withholding Common Stock | -2,701 | $108.61 | $293k | 23,714 | May 20, 2025 |
| May 16, 2025 | Brian F Kidd SVP, CFO | MOption exercise Option to Purchase Common Stockderivative | -3,734 | $0.00 | $0 | 0 | May 20, 2025 |
| May 8, 2025 | Sandra Y. Trail director | AGrant or award Option to Purchase Common Stock [2025 Grant]derivative | +7,500 | $0.00 | $0 | 7,500 | May 9, 2025 |
| May 8, 2025 | James Paul Abernathy director | AGrant or award Option to Purchase Common Stock [2025 Grant]derivative | +7,500 | $0.00 | $0 | 7,500 | May 9, 2025 |
| May 8, 2025 | Emil E Hassan director | AGrant or award Option to Purchase Common Stock [2024 Grant]derivative | +7,500 | $0.00 | $0 | 7,500 | May 9, 2025 |
| May 8, 2025 | Robert G Adams director | AGrant or award Option to Purchase Common Stock [2025 Grant]derivative | +7,500 | $0.00 | $0 | 7,500 | May 9, 2025 |
| May 8, 2025 | Richard F Laroche Jr director | AGrant or award Option to Purchase Common Stock [2025 Grant]derivative | +7,500 | $0.00 | $0 | 7,500 | May 9, 2025 |
| May 5, 2025 | Richard F Laroche Jr director | MOption exercise Common Stock (held in my name or my wife's name) | +5,000 | $64.64 | $323k | 205,912 | May 7, 2025 |
| May 5, 2025 | Richard F Laroche Jr director | MOption exercise Option to Purchase Common Stock [2020 Grant]derivative | -5,000 | $0.00 | $0 | 0 | May 7, 2025 |
| May 2, 2025 | W Andrew Adams director | MOption exercise Shares of Common Stock - Revocable Living Trust | +7,500 | $64.64 | $485k | 269,572 | May 6, 2025 |
| May 2, 2025 | W Andrew Adams director | MOption exercise Option to Purchase Common Stock [2020 Grant]derivative | -7,500 | $0.00 | $0 | 0 | May 6, 2025 |
| Apr 25, 2025 | Emil E Hassan director | MOption exercise Shares of Common Stock | +5,500 | $64.64 | $356k | 78,595 | Apr 28, 2025 |
| Apr 25, 2025 | Emil E Hassan director | MOption exercise Option to Purchase Common Stock [2020 Grant]derivative | -5,500 | $0.00 | $0 | 0 | Apr 28, 2025 |
| Mar 5, 2025 | Vicki L Dodson Sr.VP Patient Srvcs | AGrant or award Common Stock | +946 | $0.00 | $0 | 7,547 | Mar 6, 2025 |
| Mar 5, 2025 | Ben Anderson Flatt Sr Senior VP & CIO | AGrant or award Common Stock | +1,275 | $0.00 | $0 | 13,171 | Mar 6, 2025 |
| Mar 5, 2025 | Stephen Fowler Flatt CEO | AGrant or award Common Stock | +2,914 | $0.00 | $0 | 57,579 | Mar 6, 2025 |
| Mar 5, 2025 | Brian F Kidd SVP, CFO | AGrant or award Common Stock | +1,418 | $0.00 | $0 | 22,681 | Mar 5, 2025 |
| Feb 24, 2025 | Ben Anderson Flatt Sr Senior VP & CIO | AGrant or award Option to Purchase Common Stockderivative | +13,500 | $0.00 | $0 | 13,500 | Feb 26, 2025 |
| Feb 24, 2025 | Stephen Fowler Flatt CEO | AGrant or award Option to Purchase Common Stockderivative | +18,000 | $0.00 | $0 | 18,000 | Feb 26, 2025 |
| Feb 24, 2025 | Brian F Kidd SVP, CFO | AGrant or award Option to Purchase Common Stockderivative | +13,500 | $0.00 | $0 | 13,500 | Feb 26, 2025 |
| Feb 24, 2025 | Vicki L Dodson Sr.VP Patient Srvcs | AGrant or award Option to Purchase Common Stockderivative | +13,500 | $0.00 | $0 | 13,500 | Feb 26, 2025 |
| Feb 20, 2025 | James Paul Abernathy director | MOption exercise Shares of Common Stock | +1,745 | $71.64 | $125k | 35,023 | Feb 20, 2025 |
| Feb 20, 2025 | James Paul Abernathy director | MOption exercise Option to Purchase Common Stock [2021 Grant]derivative | -1,745 | $0.00 | $0 | 4,010 | Feb 20, 2025 |
| Jan 1, 2025 | Brian F Kidd SVP, Controller, PAO | FTax withholding Common Stock | -512 | $107.56 | $55k | 21,235 | Jan 3, 2025 |
| Jan 1, 2025 | Stephen Fowler Flatt CEO | FTax withholding Common Stock | -1,292 | $107.56 | $139k | 54,665 | Jan 3, 2025 |
| Jan 1, 2025 | Ben Anderson Flatt Sr Senior VP & CIO | FTax withholding Common Stock | -510 | $107.56 | $55k | 11,580 | Jan 3, 2025 |
| Jan 1, 2025 | Vicki L Dodson Sr.VP Patient Srvcs | FTax withholding Common Stock | -361 | $107.56 | $39k | 6,601 | Jan 3, 2025 |
| Dec 30, 2024 | Stephen Fowler Flatt CEO | GGift Common Stock | -885 | $0.00 | $0 | 0 | Jan 2, 2025 |
| Dec 30, 2024 | Stephen Fowler Flatt CEO | GGift Common Stock | -100 | $0.00 | $0 | 0 | Jan 2, 2025 |
| Dec 30, 2024 | Stephen Fowler Flatt CEO | GGift Common Stock | -100 | $0.00 | $0 | 55,957 | Jan 2, 2025 |
| Dec 20, 2024 | National Health Corp other | SOpen-market sale Shares of Common Stock | -28,147 | $113.71 | $3.2M | 1,056,616 | Dec 26, 2024 |
| Dec 6, 2024 | Robert Michael Ussery President & COO | GGift Shares of Common Stock owned by myself & spouse | -40 | $0.00 | $0 | 154,232 | Dec 9, 2024 |
| Dec 2, 2024 | Sandra Y. Trail director | MOption exercise Shares of Common Stock | +2,000 | $69.19 | $138k | 5,614 | Dec 2, 2024 |
| Dec 2, 2024 | Sandra Y. Trail director | MOption exercise Option to Purchase Common Stock [2022 Grant]derivative | -2,000 | $0.00 | $0 | 1,886 | Dec 2, 2024 |
| Sep 27, 2024 | W Andrew Adams director | JOther Shares of Common Stock - Adams Grandchildren's Trustindirect: Trustee | -2,307 | $0.00 | $0 | 0 | Oct 17, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- James Paul Abernathydirector
- Robert G Adamsdirector
- W Andrew Adamsdirector
- Vicki L DodsonSr.VP Patient Srvcs
- Ben Anderson Flatt SrSenior VP & CIO
- Stephen Fowler FlattCEO
- Emil E Hassandirector
- Brian F KiddSVP, CFO
- Richard F Laroche Jrdirector
- Josh A McCrearySenior VP & General Counsel
- National Health Corpother
- Sandra Y. Traildirector
- Robert Michael UsseryPresident & COO
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.